On January $1,2020,$ Holland Corporation paid $$9$ per share to a group of Zeeland Corporation shareholders to acquire $60,000$ shares of Zeeland's outstanding voting stock, representing a $60$ percent ownership interest. The remaining $40,000$ shares of Zeeland continued to trade in the market close to its recent average of $$7\mathrm{.}50$ per share both before and after the acquisition by Holland. Zeeland's acquisition date balance sheet follows:

$\backslash$table$[[\backslash$table$[[$Current assets$],[$Property and equipment $($net$)],[$Patents$]],\backslash$table$[[15,800],[309,800],[213,400]],\backslash$table$[[$Liabilities$],[$Common stock$],[$Retained earnings$]],$$$,\backslash$table$[[239,000],[100,000],[200,000]]],[,$$$539,000,,$$$,539,000]]$

On January $1,2020,$ Holland assessed the carrying amount of Zeeland's equipment $(5-$year remaining life$)$ to be undervalued by $$49,000.$ Holland also determined that Zeeland possessed unrecorded patents $(10-$year remaining life$)$ worth $$391,500.$ Zeeland's acquisition$-$date fair values for its current assets and liabilities were equal to their carrying amounts. Any remaining excess of Zeeland's acquisition$-$date fair value over its book value was attributed to goodwill.

The companies' financial statements for the year ending December $31,2021,$ follow:

$\backslash$table$[[,,$Holland,,Zeeland$],[\backslash$table$[[$Sales$],[$Cost of goods sold$],[$Depreciation expense$],[$Amortization expense$],[$Other operating expenses$],[$Equity in Zeeland earnings$]],$$$,\backslash$table$[[(570,900)$